Cancer tumors hijack genetic program of developing nerves, study shows

Cancer tumors “hijack” the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden.

As supply crunch starts to ease, Novo Nordisk to offer more doses of obesity drug Wegovy to U.S. patients

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the

January 31, 2024

Deciphera says its drug for rare joint tumor succeeded in a PhIII study, will submit to FDA

Deciphera Pharmaceuticals’ experimental treatment for tenosynovial giant cell tumor passed a pivotal study, setting the biotech up to go for its second drug approval. In

October 31, 2023

Hims & Hers Now Offers In-Person Care in Connecticut with Hartford HealthCare Partnership

What You Should Know: Hims & Hers Health, Inc., the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today

January 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.